This review emphasizes the significance of cardiovascular implications in ankylosing spondylitis (AS) and axial spondyloarthritis (axSpA), highlighting the increased risk of cardiovascular disease in these patients.
Key Findings:
The review found that the prevalence rates of subclinical abnormalities, such as left ventricular hypertrophy and increased arterial stiffness, are notably higher in patients with AS/axSpA compared to the general population.
Interpretation:
There is a critical need for integrated management strategies that address both musculoskeletal and cardiovascular health in patients with AS and axSpA.
Limitations:
The review's comprehensiveness may be impacted by language restrictions, limiting the inclusion of relevant studies published in non-English languages.
Conclusion:
Ongoing research into the cardiovascular implications of AS and axSpA is essential to improve patient outcomes and inform clinical practice.
